ResearcherKyoto UniversityNo recent work listed
Shigeo Takaishi
Matched on ORCID iD 0000-0003-2236-6081; OpenAlex author ID A5049130190. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper
Papers 4
- Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer. Co-author DOI 10.1186/s12885-022-09619-9↗
- SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2. Last author DOI 10.1111/cas.15162↗
- Promoter-Level Transcriptome Identifies Stemness Associated With Relatively High Proliferation in Pancreatic Cancer Cells. Co-author DOI 10.3389/fonc.2020.00316↗
- Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. Co-author DOI 10.1136/gutjnl-2017-315425↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hiroshi Seno · 4 shared papers, 2019–2022 · strength 0.47
- Paper Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancre… DOI 10.1186/s12885-022-09619-9↗
- Paper SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2. DOI 10.1111/cas.15162↗
- Paper Promoter-Level Transcriptome Identifies Stemness Associated With Relatively High Proliferation in Pancreatic Cancer Cel… DOI 10.3389/fonc.2020.00316↗
- Shinji Üemoto · 3 shared papers, 2019–2022 · strength 0.35
- Paper Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancre… DOI 10.1186/s12885-022-09619-9↗
- Paper SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2. DOI 10.1111/cas.15162↗
- Paper Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. DOI 10.1136/gutjnl-2017-315425↗
- Akihisa Fukuda · 3 shared papers, 2019–2021 · strength 0.33
- Paper SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2. DOI 10.1111/cas.15162↗
- Paper Promoter-Level Transcriptome Identifies Stemness Associated With Relatively High Proliferation in Pancreatic Cancer Cel… DOI 10.3389/fonc.2020.00316↗
- Paper Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. DOI 10.1136/gutjnl-2017-315425↗
- Toshihiko Masui · 2 shared papers, 2021–2022 · strength 0.28
- Kenji Masuo · 2 shared papers, 2019–2021 · strength 0.21
- Sadanori Watanabe · 1 shared paper, 2022 · strength 0.15
- Etsuro Hatano · 1 shared paper, 2022 · strength 0.15
- Ru Chen · 1 shared paper, 2020 · strength 0.12
- Yoshito Kimura · 1 shared paper, 2019 · strength 0.07
- Kozo Ikuta · 1 shared paper, 2019 · strength 0.07
- Tsutomu Chiba · 1 shared paper, 2019 · strength 0.07
- Yuto Kimura · 1 shared paper, 2019 · strength 0.07
- Takahisa Maruno · 1 shared paper, 2019 · strength 0.07
- Motoyuki Tsuda · 1 shared paper, 2019 · strength 0.07
- Satoshi Ogawa · 1 shared paper, 2019 · strength 0.07
- Kyoichi Takaori · 1 shared paper, 2019 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.